To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene UBE2E3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
509 supporting clones for gene UBE2E3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BQ931727 epidermoid carcinoma, cell line, lung .a 1 to 752 1 to 753   tiling clone,   753/933
(80 %)
13 diff
(98.7 %id)
BQ932163 epidermoid carcinoma, cell line, lung .a 10 to 902 1 to 897       897/900
(99 %)
6 diff
(99.4 %id)
NM_182678.1   .a 10 to 1387 1 to 1378   RefSeq, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1378/1378
(100 %)
0 diff
(100 %id)
H12272 whole brain .a 160 to 588 1 to 429     Submitted on the opposite strand 429/432
(99 %)
10 diff
(97.7 %id)
CF455345 peripheral nervous system .a 160 to 880 28 to 748       721/748
(96 %)
6 diff
(99.2 %id)
AL536983.
matches multiple genes
brain, fetal brain .a 161 to 473 328 to 639     also hits gene UBE2E4P 312/376
(82 %)
25 diff
(93.4 %id)
BG714435 brain, hypothalamus .a 163 to 869 1 to 708       708/708
(100 %)
9 diff
(98.8 %id)
DN990947 brain, whole brain .a 163 to 778 1 to 616       616/616
(100 %)
5 diff
(99.2 %id)
CB215235 normal endometrium, late proliferativephase, cycle day 13, uterus .a 166 to 723 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
CB215063 normal endometrium, late proliferativephase, cycle day 13, uterus .a 167 to 705 1 to 539       539/539
(100 %)
0 diff
(100 %id)
AB017644 gastric adenocarcinoma .a 168 to 1383 1 to 1216   tiling clone,   1216/1216
(100 %)
0 diff
(100 %id)
DB487017 hypothalamus .a 168 to 608 1 to 440       440/443
(99 %)
4 diff
(99.1 %id)
CN420954 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 172 to 845 1 to 674       674/674
(100 %)
1 diff
(99.9 %id)
BG472733 eye, retinoblastoma .a 172 to 1083 1 to 909       909/953
(95 %)
47 diff
(95.1 %id)
CX870530 embryonic stem .a 177 to 984 1 to 809       809/809
(100 %)
1 diff
(99.9 %id)
DB498468 hypothalamus .a 180 to 693 1 to 514       514/514
(100 %)
4 diff
(99.3 %id)
CN420949 embryonic stem cells, DMSO-treated H9 cellline .a 182 to 874 8 to 702       695/702
(99 %)
13 diff
(98.2 %id)
BU528288 epidermoid carcinoma, cell line, lung .a 182 to 939 1 to 761       761/921
(82 %)
9 diff
(99.1 %id)
BE256597 eye, retinoblastoma .a 192 to 815 1 to 623       623/623
(100 %)
2 diff
(99.7 %id)
BI256466 cervical carcinoma cell line, cervix .a 193 to 999 1 to 810       810/810
(100 %)
6 diff
(99.3 %id)
BM548845 duodenal adenocarcinoma, cell line, small intestine .a 196 to 1162 1 to 976       976/1004
(97 %)
26 diff
(97.5 %id)
BG756114 B-cells, primary B-cells from tonsils (cell line) .a 201 to 928 191 to 917       727/919
(79 %)
14 diff
(98.5 %id)
BG197373   .a 202 to 1003 39 to 836       798/853
(93 %)
24 diff
(97.2 %id)
BG183402   .a 204 to 1009 1 to 805       805/808
(99 %)
14 diff
(98.3 %id)
BG184965   .a 204 to 1009 1 to 806       806/813
(99 %)
12 diff
(98.6 %id)
BG187677   .a 204 to 968 1 to 765       765/765
(100 %)
4 diff
(99.5 %id)
BG188658   .a 204 to 1040 1 to 833       833/835
(99 %)
13 diff
(98.5 %id)
BG191767   .a 204 to 1059 1 to 847       847/881
(96 %)
24 diff
(97.3 %id)
BG193868   .a 204 to 1096 1 to 893       893/894
(99 %)
17 diff
(98.1 %id)
BG194354   .a 204 to 1026 1 to 812       812/819
(99 %)
27 diff
(96.8 %id)
BG196398   .a 204 to 938 1 to 725       725/813
(89 %)
36 diff
(95.6 %id)
BG198382   .a 204 to 946 1 to 736       736/776
(94 %)
17 diff
(97.9 %id)
BG198383   .a 204 to 1030 1 to 814       814/816
(99 %)
25 diff
(97.0 %id)
BG203091   .a 204 to 1030 1 to 825       825/830
(99 %)
21 diff
(97.5 %id)
BG205124   .a 204 to 945 1 to 742       742/743
(99 %)
3 diff
(99.6 %id)
BG205660   .a 204 to 1002 1 to 794       794/801
(99 %)
11 diff
(98.7 %id)
BG210386   .a 204 to 1005 1 to 798       798/798
(100 %)
19 diff
(97.7 %id)
BG212488   .a 204 to 983 1 to 777       777/779
(99 %)
20 diff
(97.5 %id)
BG217810   .a 204 to 881 1 to 675       675/771
(87 %)
23 diff
(97.1 %id)
BG218319   .a 204 to 1030 1 to 818       818/872
(93 %)
23 diff
(97.4 %id)
BG218320   .a 204 to 947 1 to 746       724/768
(94 %)
55 diff
(92.9 %id)
BG218833   .a 204 to 849 1 to 649       649/818
(79 %)
28 diff
(96.6 %id)
BG219311   .a 204 to 949 1 to 745       745/876
(85 %)
45 diff
(94.9 %id)
CN420956 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 207 to 780 1 to 574       574/574
(100 %)
0 diff
(100 %id)
CR593046 Neuroblastoma Cot 50-normalized .a 212 to 1332 1 to 1121       1121/1121
(100 %)
0 diff
(100 %id)
AL528814 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 212 to 785 1 to 574   fully sequenced,   574/574
(100 %)
1 diff
(99.9 %id)
BP369897 testis .a 225 to 804 1 to 580       580/582
(99 %)
2 diff
(99.7 %id)
BE887721 leiomyosarcoma, uterus .a 228 to 876 1 to 652       652/858
(75 %)
6 diff
(99.4 %id)
BT019345   .a 229 to 851 1 to 623       623/624
(99 %)
1 diff
(99.9 %id)
TI_1948090225   .a 229 to 650 135 to 556   fully sequenced,   422/451
(93 %)
0 diff
(100 %id)
BP264993 muscle .a 233 to 1087 1 to 867       867/894
(96 %)
21 diff
(97.7 %id)
CF456760 peripheral nervous system .a 234 to 977 33 to 776       744/776
(95 %)
6 diff
(99.3 %id)
BG289153 bladder, transitional cell papilloma, cell line .a 236 to 1003 1 to 767       767/1060
(72 %)
11 diff
(99.0 %id)
BF685557 leiomyosarcoma cell line, uterus .a 239 to 1040 1 to 805       805/864
(93 %)
21 diff
(97.6 %id)
BQ918763 brain, neuroblastoma, cell line .a 239 to 1104 1 to 870       870/921
(94 %)
18 diff
(98.1 %id)
BG329039 eye, retinoblastoma .a 248 to 1068 1 to 814       814/815
(99 %)
18 diff
(97.8 %id)
AL578479.
matches multiple genes
placenta .a 269 to 1343 1077 to 13     also hits gene UBE2E4P 1065/1088
(97 %)
17 diff
(98.5 %id)
BM927792 hepatocellular carcinoma, cell line, Liver .a 269 to 1250 1 to 986   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 986/986
(100 %)
17 diff
(98.3 %id)
CB135113 Liver .a 297 to 876 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BG751423 eye, normal pigmented retinal epithelium .a 301 to 1209 1 to 913       913/961
(95 %)
26 diff
(97.3 %id)
CD104233 Pooled-Skin .a 328 to 1033 1 to 710       710/711
(99 %)
7 diff
(99.1 %id)
AW368494 head_neck .a 335 to 800 15 to 480       466/485
(96 %)
11 diff
(97.8 %id)
BE695982 colon .a 335 to 800 469 to 7       463/469
(98 %)
2 diff
(99.6 %id)
BG927180 cartilage .a 340 to 862 86 to 608       523/540
(96 %)
6 diff
(98.9 %id)
CN420946 embryonic stem cells, DMSO-treated H9 cellline .a 377 to 766 1 to 392       392/392
(100 %)
4 diff
(99.0 %id)
BP228112   .a 393 to 959 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
CN420951 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 413 to 846 9 to 442       434/442
(98 %)
0 diff
(100 %id)
N47190 multiple sclerosis lesions .a 422 to 633 1 to 212       212/212
(100 %)
0 diff
(100 %id)
TI_1948090226   .a 620 to 857 355 to 118   fully sequenced,   238/355
(67 %)
0 diff
(100 %id)
AL563255 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 720 to 1332 613 to 1   fully sequenced,   613/613
(100 %)
8 diff
(98.7 %id)
N46869 multiple sclerosis lesions .a 907 to 1383 479 to 1       479/479
(100 %)
2 diff
(99.6 %id)
H12273 whole brain .a 1093 to 1358 275 to 3     Submitted on the opposite strand 273/275
(99 %)
0 diff
(100 %id)
BQ643266 lymph, lymphoma, cell line .b 1 to 850 1 to 857 K209R V210F L211C L212C S213L ... tiling clone,   857/946
(90 %)
29 diff
(97.0 %id)
BG185493   .b 667 to 1293 637 to 10     Submitted on the opposite strand 628/878
(71 %)
0 diff
(100 %id)
BG190774   .b 667 to 1293 634 to 11     Submitted on the opposite strand 624/862
(72 %)
0 diff
(100 %id)
BG197886   .b 667 to 1264 604 to 9     Submitted on the opposite strand 596/901
(66 %)
0 diff
(100 %id)
BG198385   .b 667 to 1291 635 to 12     Submitted on the opposite strand 624/822
(75 %)
0 diff
(100 %id)
BG205125   .b 667 to 1292 642 to 14     Submitted on the opposite strand 629/831
(75 %)
0 diff
(100 %id)
BG210388   .b 667 to 1290 638 to 14     Submitted on the opposite strand 625/845
(73 %)
0 diff
(100 %id)
BM970528 lung .b 667 to 1304 656 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 638/643
(99 %)
1 diff
(99.9 %id)
BG194353   .b 670 to 1290 634 to 14     Submitted on the opposite strand 621/883
(70 %)
0 diff
(100 %id)
BG196399   .b 670 to 1293 635 to 11     Submitted on the opposite strand 625/873
(71 %)
0 diff
(100 %id)
AI831623 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 673 to 1307 640 to 6       635/685
(92 %)
0 diff
(100 %id)
BG183403   .b 677 to 1304 1 to 629       629/787
(79 %)
21 diff
(97.4 %id)
CA420047 Bone, Human Chondrosarcoma Cell Line .b 680 to 1299 638 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 620/620
(100 %)
1 diff
(99.9 %id)
CA427413 Cell Line, Chondrosarcoma .b 680 to 1301 638 to 17       622/638
(97 %)
0 diff
(100 %id)
BQ020873 lung, Metastatic Chondrosarcoma .b 681 to 1303 641 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 623/623
(100 %)
0 diff
(100 %id)
CA420706 Bone, Enchondroma cell line .b 681 to 1299 636 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 618/618
(100 %)
1 diff
(99.9 %id)
CA306914 Alveolar Macrophage, lung .b 681 to 1299 636 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 618/618
(100 %)
1 diff
(99.9 %id)
CA429895 Cell Line, Chondrosarcoma .b 686 to 1303 634 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 616/616
(100 %)
3 diff
(99.6 %id)
BU687233 lung .b 688 to 1304 635 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 617/617
(100 %)
12 diff
(98.1 %id)
BG193869.
matches multiple genes
  .b 690 to 1291 613 to 12     Submitted on the opposite strand, also hits gene UBE2E4P 602/856
(70 %)
0 diff
(100 %id)
BM750299 stomach .b 690 to 1253 1 to 564       564/564
(100 %)
0 diff
(100 %id)
AA744548 germinal center B cell .b 694 to 1299 622 to 18   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 605/608
(99 %)
25 diff
(95.9 %id)
BQ327600 kidney_tumor .b 709 to 1172 504 to 41       464/513
(90 %)
15 diff
(97.1 %id)
AA470054   .b 710 to 1089 1 to 380   fully sequenced,   380/380
(100 %)
0 diff
(100 %id)
BU532501 mixed (pool of 40 RNAs) .b 720 to 1301 1 to 582       582/584
(99 %)
2 diff
(99.7 %id)
AA460511   .b 729 to 1196 1 to 467   fully sequenced,   467/467
(100 %)
1 diff
(99.8 %id)
W07667 lung .b 731 to 975 1 to 246   fully sequenced,   246/246
(100 %)
0 diff
(100 %id)
BE795016 lung, small cell carcinoma .b 745 to 1303 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
AW248558 lung, small cell carcinoma .b 752 to 1304 563 to 11   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 553/553
(100 %)
0 diff
(100 %id)
AI304316 adenocarcinoma, colon .b 754 to 1307 556 to 2       555/556
(99 %)
0 diff
(100 %id)
AA448500   .b 760 to 1204 1 to 445       445/445
(100 %)
0 diff
(100 %id)
BX455304.
matches multiple genes
brain, fetal brain .b 765 to 1290 534 to 11     also hits gene UBE2E4P 524/631
(83 %)
0 diff
(100 %id)
BI036972 nervous_tumor .b 766 to 1149 383 to 1       383/383
(100 %)
1 diff
(99.8 %id)
AA781577 parathyroid gland, parathyroid tumor .b 774 to 1301 533 to 5       529/533
(99 %)
0 diff
(100 %id)
AI955795 adenocarcinoma, Pancreas .b 780 to 1301 527 to 5       523/527
(99 %)
0 diff
(100 %id)
N53510 multiple sclerosis lesions .b 795 to 1299 504 to 1       504/504
(100 %)
5 diff
(99.1 %id)
AI185152 lung .b 797 to 1304 519 to 14   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 506/506
(100 %)
2 diff
(99.7 %id)
AI422964 brain, glioblastoma (pooled) .b 799 to 1306 508 to 1       508/508
(100 %)
0 diff
(100 %id)
AI571353 anaplastic oligodendroglioma, brain .b 799 to 1304 506 to 1       506/506
(100 %)
0 diff
(100 %id)
DV459295 cochlea, ear .b 800 to 1027 1 to 228       228/228
(100 %)
0 diff
(100 %id)
AI313197 lung .b 801 to 1303 504 to 2       503/504
(99 %)
0 diff
(100 %id)
AI185163 lung .b 806 to 1304 512 to 14   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 499/499
(100 %)
0 diff
(100 %id)
AA759128   .b 807 to 1303 497 to 3       495/497
(99 %)
0 diff
(100 %id)
AA864949 Kidney, kidney tumor .b 811 to 1251 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AI696978 adenocarcinoma, Pancreas .b 812 to 1307 497 to 3       495/497
(99 %)
0 diff
(100 %id)
AI371028 lung .b 814 to 1305 494 to 3       492/494
(99 %)
0 diff
(100 %id)
BI962902 Islets of Langerhans, Pancreas .b 815 to 1243 1 to 429       429/429
(100 %)
0 diff
(100 %id)
BI962941 Islets of Langerhans, Pancreas .b 815 to 1305 1 to 491       491/492
(99 %)
1 diff
(99.8 %id)
AW439404 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 816 to 1299 497 to 14   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 484/484
(100 %)
1 diff
(99.8 %id)
BE909535 epithelioid carcinoma, Pancreas .b 819 to 1301 1 to 483       483/485
(99 %)
1 diff
(99.8 %id)
BU686786 lung, Primary Lung Epithelial Cells .b 820 to 1299 498 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 480/480
(100 %)
3 diff
(99.4 %id)
AI150883 brain, glioblastoma (pooled) .b 821 to 1306 486 to 1       486/486
(100 %)
0 diff
(100 %id)
BU954477 mixed (pool of 40 RNAs) .b 822 to 1303 1 to 484       484/518
(93 %)
3 diff
(99.5 %id)
AI335852 pooled germ cell tumors .b 828 to 1307 483 to 4       480/483
(99 %)
0 diff
(100 %id)
DB574806 hypothalamus .b 829 to 1304 1 to 476     Submitted on the opposite strand 476/476
(100 %)
4 diff
(99.2 %id)
DB569548 hypothalamus .b 833 to 1297 1 to 465     Submitted on the opposite strand 465/467
(99 %)
4 diff
(99.2 %id)
AI859544 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 835 to 1304 488 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 472/472
(100 %)
3 diff
(99.4 %id)
BQ669392 epidermoid carcinoma, cell line, salivary gland .b 835 to 1303 1 to 468   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 468/468
(100 %)
7 diff
(98.6 %id)
BQ671204 epidermoid carcinoma, cell line, salivary gland .b 836 to 1303 1 to 467   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 467/467
(100 %)
1 diff
(99.8 %id)
BQ674993 epidermoid carcinoma, cell line, salivary gland .b 836 to 1303 1 to 467   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 467/467
(100 %)
1 diff
(99.8 %id)
BQ671228 epidermoid carcinoma, cell line, salivary gland .b 836 to 1303 1 to 467   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 467/467
(100 %)
1 diff
(99.8 %id)
AA948038 carcinoid, lung .b 838 to 1299 488 to 27   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 462/462
(100 %)
2 diff
(99.6 %id)
AI128795 heart .b 838 to 1305 468 to 2       467/468
(99 %)
0 diff
(100 %id)
DB570847 hypothalamus .b 839 to 1299 1 to 461     Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
DB527852 testis .b 840 to 1304 1 to 463     Submitted on the opposite strand 463/463
(100 %)
2 diff
(99.6 %id)
AV738245 cord Blood .b 845 to 1303 26 to 474   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 449/475
(94 %)
9 diff
(98.2 %id)
AI369825 anaplastic oligodendroglioma, brain .b 845 to 1304 460 to 1       460/460
(100 %)
0 diff
(100 %id)
DB528845 hippocampus .b 850 to 1304 1 to 450     Submitted on the opposite strand 450/450
(100 %)
21 diff
(95.4 %id)
DB543719 hippocampus .b 852 to 1304 1 to 453     Submitted on the opposite strand 453/453
(100 %)
1 diff
(99.8 %id)
AA934724 pooled germ cell tumors .b 852 to 1305 454 to 2       453/454
(99 %)
0 diff
(100 %id)
AI751885 Bone, Hip .b 852 to 1122 279 to 9       271/279
(97 %)
0 diff
(100 %id)
BF512726   .b 853 to 1299 464 to 18   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 447/447
(100 %)
0 diff
(100 %id)
BE769759 prostate_tumor .b 854 to 1185 343 to 12       332/344
(96 %)
0 diff
(100 %id)
CN420957 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 854 to 1301 1 to 448       448/448
(100 %)
0 diff
(100 %id)
BF055247 pooled .b 854 to 1301 453 to 6       448/453
(98 %)
0 diff
(100 %id)
DB535568 hippocampus .b 856 to 1299 1 to 444     Submitted on the opposite strand 444/444
(100 %)
5 diff
(98.9 %id)
AI192983 lung .b 857 to 1303 453 to 6       448/453
(98 %)
0 diff
(100 %id)
BQ018098 Fibrosarcoma .b 857 to 1304 466 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 448/448
(100 %)
3 diff
(99.4 %id)
AI167362 senescent fibroblast .b 859 to 1301 448 to 6       443/448
(98 %)
0 diff
(100 %id)
AI970652 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 859 to 1305 454 to 8       447/454
(98 %)
0 diff
(100 %id)
AI933159 anaplastic oligodendroglioma, brain .b 860 to 1305 452 to 3       450/452
(99 %)
0 diff
(100 %id)
AI023406 liver and spleen .b 861 to 1302 460 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 442/442
(100 %)
0 diff
(100 %id)
AI056657 liver and spleen .b 870 to 1302 433 to 1       433/433
(100 %)
0 diff
(100 %id)
H98698.
matches multiple genes
melanocyte .b 871 to 1299 429 to 1     also hits gene UBE2E4P 429/429
(100 %)
2 diff
(99.6 %id)
AA020993 eye, retina .b 877 to 1304 434 to 1       434/434
(100 %)
5 diff
(98.9 %id)
AA936842 adenocarcinoma, colon .b 880 to 1299 420 to 1       420/420
(100 %)
1 diff
(99.8 %id)
BC003687 Placenta, choriocarcinoma .b 880 to 1299 1 to 420   available from MGC, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 420/420
(100 %)
0 diff
(100 %id)
AI301282 2 pooled tumors (clear cell type), Kidney .b 882 to 1307 433 to 8       426/433
(98 %)
0 diff
(100 %id)
AI348453 carcinoid, lung .b 883 to 1299 417 to 1       417/417
(100 %)
0 diff
(100 %id)
T03564   .b 885 to 1299 414 to 1       414/456
(90 %)
8 diff
(98.3 %id)
DB556346 hypothalamus .b 889 to 1299 1 to 411   AAA Submitted on the opposite strand 411/411
(100 %)
1 diff
(99.8 %id)
DB556767 hypothalamus .b 889 to 1307 1 to 421     Submitted on the opposite strand 421/428
(98 %)
11 diff
(97.5 %id)
AI014303 brain, pooled frontal lobe .b 894 to 1305 416 to 6       411/421
(97 %)
0 diff
(100 %id)
BE769753 prostate_tumor .b 895 to 1185 302 to 12       291/302
(96 %)
0 diff
(100 %id)
AI038444 parathyroid gland, parathyroid tumor .b 895 to 1303 421 to 13   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 409/409
(100 %)
0 diff
(100 %id)
AI249484 lymph node, lymphoma, follicular mixed small and largecell .b 896 to 1304 425 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 409/409
(100 %)
1 diff
(99.8 %id)
AA709334 heart .b 899 to 1305 409 to 3       407/409
(99 %)
0 diff
(100 %id)
AI312674 lung .b 899 to 1303 409 to 5       405/409
(99 %)
0 diff
(100 %id)
AI568703 B-cell, chronic lymphotic leukemia .b 899 to 1301 407 to 5       403/407
(99 %)
0 diff
(100 %id)
BE540573 cervix .b 901 to 1299 1 to 395   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 395/395
(100 %)
4 diff
(99.0 %id)
BE790027 large cell carcinoma, lung .b 902 to 1526 1 to 625   tiling clone,   625/625
(100 %)
9 diff
(98.6 %id)
AI057225 liver and spleen .b 903 to 1306 404 to 1       404/404
(100 %)
0 diff
(100 %id)
AA602321 normal prostate, Prostate .b 905 to 1303 402 to 5       398/402
(99 %)
0 diff
(100 %id)
AV754922 pituitary tumor .b 905 to 1286 374 to 3     Submitted on the opposite strand 372/374
(99 %)
0 diff
(100 %id)
AA808641 germinal center B cell .b 907 to 1299 410 to 18   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 393/393
(100 %)
2 diff
(99.5 %id)
AA973884 pooled germ cell tumors .b 908 to 1301 398 to 5       394/398
(98 %)
0 diff
(100 %id)
AA720593 germinal center B cell .b 909 to 1299 419 to 29   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 391/391
(100 %)
1 diff
(99.8 %id)
AA626030   .b 910 to 1303 397 to 4       394/397
(99 %)
0 diff
(100 %id)
AI084547   .b 910 to 1185 276 to 1       276/276
(100 %)
0 diff
(100 %id)
AW591539 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 911 to 1301 393 to 3       391/393
(99 %)
0 diff
(100 %id)
CB158187 Liver .b 912 to 1306 430 to 36   AAA Submitted on the opposite strand 395/395
(100 %)
0 diff
(100 %id)
EC510007 Prostate .b 916 to 1019 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
AI199491 anaplastic oligodendroglioma, brain .b 916 to 1304 399 to 11   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 389/398
(97 %)
0 diff
(100 %id)
AI420992 Prostate .b 916 to 1249 334 to 1       334/334
(100 %)
0 diff
(100 %id)
AW058033 thymus, pooled .b 919 to 1303 396 to 11   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 386/386
(100 %)
4 diff
(99.0 %id)
N41767 placenta .b 921 to 1278 359 to 1     Submitted on the opposite strand 359/359
(100 %)
1 diff
(99.8 %id)
AI368079 adenocarcinoma, colon .b 923 to 1307 386 to 2       385/386
(99 %)
0 diff
(100 %id)
T32967 brain .b 927 to 1304 378 to 1       378/378
(100 %)
1 diff
(99.8 %id)
AW514017 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 933 to 1304 383 to 12   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 372/372
(100 %)
0 diff
(100 %id)
AA908647 carcinoid, lung .b 942 to 1299 358 to 1       358/358
(100 %)
0 diff
(100 %id)
AA568156 colon, colon tumor RER+ .b 944 to 1301 359 to 2       358/359
(99 %)
0 diff
(100 %id)
AA670069 bone marrow stroma .b 944 to 1306 390 to 29   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 362/366
(98 %)
1 diff
(99.8 %id)
N81039 lung .b 945 to 1304 359 to 1   fully sequenced,   359/359
(100 %)
1 diff
(99.8 %id)
AA054004 eye, retina .b 945 to 1304 360 to 1       360/360
(100 %)
0 diff
(100 %id)
AA256083 germinal center B cell .b 950 to 1297 347 to 1     Submitted on the opposite strand 347/347
(100 %)
2 diff
(99.5 %id)
AI630758 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 950 to 1300 351 to 1       351/351
(100 %)
3 diff
(99.2 %id)
BG212059   .b 957 to 1292 348 to 12     Submitted on the opposite strand 337/348
(96 %)
0 diff
(100 %id)
BG181849   .b 960 to 1291 384 to 53     Submitted on the opposite strand 332/384
(86 %)
0 diff
(100 %id)
R41618 whole brain .b 968 to 1299 356 to 14   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 343/343
(100 %)
17 diff
(95.1 %id)
AA903756 pooled germ cell tumors .b 971 to 1321 357 to 7       351/357
(98 %)
0 diff
(100 %id)
BF445619 brain, glioblastoma (pooled) .b 972 to 1306 335 to 1       372/393
(94 %)
10 diff
(97.5 %id)
AI160240 brain, glioblastoma (pooled) .b 974 to 1306 333 to 1       333/364
(91 %)
2 diff
(99.5 %id)
AI589145 brain, glioblastoma (pooled) .b 974 to 1306 333 to 1       333/364
(91 %)
2 diff
(99.5 %id)
BE858644 brain, glioblastoma (pooled) .b 974 to 1306 333 to 1       333/371
(89 %)
2 diff
(99.5 %id)
BF939884 brain, glioblastoma (pooled) .b 974 to 1306 333 to 1       333/364
(91 %)
2 diff
(99.5 %id)
BG054803 brain, glioblastoma (pooled) .b 974 to 1306 333 to 1       333/364
(91 %)
3 diff
(99.2 %id)
AW519261 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 981 to 1303 324 to 2       323/324
(99 %)
0 diff
(100 %id)
EC525057 Prostate .b 984 to 1088 1 to 105       105/105
(100 %)
1 diff
(99.1 %id)
AI475440 colon, moderately-differentiated adenocarcinoma .b 987 to 1301 318 to 4       315/318
(99 %)
0 diff
(100 %id)
BF432703 brain, glioblastoma (pooled) .b 998 to 1306 309 to 1       309/309
(100 %)
0 diff
(100 %id)
AW797801 uterus .b 999 to 1215 46 to 262       217/262
(82 %)
6 diff
(97.8 %id)
AW797860 uterus .b 999 to 1215 31 to 247       217/247
(87 %)
6 diff
(97.6 %id)
H18524 brain .b 1001 to 1303 308 to 3       306/308
(99 %)
0 diff
(100 %id)
AI073732 senescent fibroblast .b 1003 to 1305 307 to 5       303/307
(98 %)
0 diff
(100 %id)
BG215152   .b 1010 to 1289 324 to 46     Submitted on the opposite strand 279/324
(86 %)
0 diff
(100 %id)
AA954180 Kidney, kidney tumor .b 1015 to 1302 288 to 1       288/299
(96 %)
0 diff
(100 %id)
DB530896 hippocampus .b 1019 to 1298 1 to 278   AAA Submitted on the opposite strand 278/278
(100 %)
16 diff
(94.3 %id)
AA864850 Kidney .b 1023 to 1299 293 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 277/277
(100 %)
0 diff
(100 %id)
AA977386 2 pooled tumors (clear cell type), Kidney .b 1023 to 1307 292 to 8       285/292
(97 %)
0 diff
(100 %id)
BG217274   .b 1024 to 1290 321 to 56     Submitted on the opposite strand 266/321
(82 %)
0 diff
(100 %id)
AW661944 2 pooled high-grade transitional celltumors, genitourinary tract .b 1032 to 1304 283 to 11   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 273/273
(100 %)
0 diff
(100 %id)
AA731196 germinal center B cell .b 1034 to 1303 286 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 270/270
(100 %)
0 diff
(100 %id)
T31441 colon, embryo .b 1038 to 1299 1 to 262       262/262
(100 %)
0 diff
(100 %id)
AW952445   .b 1039 to 1299 1 to 261   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 261/261
(100 %)
0 diff
(100 %id)
H80524.
matches multiple genes
liver and spleen .b 1043 to 1306 266 to 1     also hits gene UBE2E4P 266/266
(100 %)
2 diff
(99.3 %id)
CA441176 Fibrosarcoma .b 1050 to 1304 273 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 284/313
(90 %)
10 diff
(96.9 %id)
BG198929   .b 1051 to 1290 293 to 54     Submitted on the opposite strand 240/293
(81 %)
0 diff
(100 %id)
AA416893   .b 1059 to 1310 252 to 1   fully sequenced,   252/252
(100 %)
4 diff
(98.5 %id)
AW149176 Kidney, renal cell tumor .b 1068 to 1299 248 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 232/232
(100 %)
3 diff
(98.8 %id)
BF985774 placenta_normal .b 1072 to 1184 1 to 113       113/128
(88 %)
2 diff
(98.5 %id)
N80003 lung .b 1075 to 1304 231 to 1       231/231
(100 %)
2 diff
(99.2 %id)
BI493297 cochlea, ear .b 1078 to 1303 8 to 233   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 226/233
(96 %)
6 diff
(97.5 %id)
BG210496.
matches multiple genes
  .b 1086 to 1291 218 to 12     Submitted on the opposite strand, also hits gene UBE2E4P 207/221
(93 %)
0 diff
(100 %id)
BG216776   .b 1095 to 1290 246 to 52   AAA Submitted on the opposite strand 195/219
(89 %)
0 diff
(100 %id)
AA477003 ovarian tumor, ovary .b 1098 to 1300 1 to 203       203/203
(100 %)
2 diff
(99.1 %id)
AI872803 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 1098 to 1299 202 to 1       202/202
(100 %)
0 diff
(100 %id)
BG199995   .b 1099 to 1290 251 to 59     Submitted on the opposite strand 193/251
(76 %)
0 diff
(100 %id)
BM271722 Pancreas, Purified pancreatic islet .b 1099 to 1297 217 to 19   AAA   199/206
(96 %)
0 diff
(100 %id)
DB557542 hypothalamus .b 1099 to 1304 1 to 206     Submitted on the opposite strand 206/206
(100 %)
7 diff
(96.7 %id)
AA016236 heart .b 1112 to 1303 192 to 1       192/192
(100 %)
0 diff
(100 %id)
T35431 lung .b 1112 to 1302 1 to 192       192/192
(100 %)
1 diff
(99.5 %id)
AV754432 pituitary tumor .b 1142 to 1286 143 to 3     Submitted on the opposite strand 141/161
(87 %)
0 diff
(100 %id)
C20582   .b 1152 to 1304 1 to 153       153/153
(100 %)
0 diff
(100 %id)
D25627   .b 1152 to 1301 1 to 150     Submitted on the opposite strand 150/151
(99 %)
1 diff
(99.4 %id)
BG204589   .b 1165 to 1293 157 to 28     Submitted on the opposite strand 130/157
(82 %)
0 diff
(100 %id)
AA459868   .b 1166 to 1307 141 to 1   fully sequenced,   141/141
(100 %)
1 diff
(99.3 %id)
AI475258 colon, moderately-differentiated adenocarcinoma .b 1227 to 1306 95 to 16   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 80/80
(100 %)
1 diff
(98.8 %id)
AA076000   .b 1260 to 1307 1 to 48     Submitted on the opposite strand 48/50
(96 %)
1 diff
(98.0 %id)
BI257596 cervical carcinoma cell line, cervix .c 1 to 812 1 to 810 C81L S82Q A83C G84W P85A ... tiling clone,   808/869
(92 %)
30 diff
(96.6 %id)
AI870539 anaplastic oligodendroglioma, brain .c 808 to 1379 567 to 1   tiling clone,   567/567
(100 %)
2 diff
(99.7 %id)
BG723793 testis .d 1 to 705 1 to 705   tiling clone,   705/706
(99 %)
7 diff
(99.1 %id)
BG395655 eye, retinoblastoma .d 111 to 990 1 to 883       883/913
(96 %)
21 diff
(97.7 %id)
BG396662 eye, retinoblastoma .d 111 to 703 1 to 589       589/590
(99 %)
7 diff
(98.9 %id)
BE259065 eye, retinoblastoma .d 112 to 749 10 to 646       637/646
(98 %)
7 diff
(99.0 %id)
CB857013 anterior tongue, pooled .d 154 to 780 1 to 627   tiling clone,   627/627
(100 %)
0 diff
(100 %id)
CN420945 embryonic stem cells, DMSO-treated H9 cellline .d 182 to 680 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BG204587   .d 623 to 1435 1 to 818   tiling clone,   818/819
(99 %)
15 diff
(98.2 %id)
T19225.
matches multiple genes
  .d 623 to 957 1 to 335     also hits gene SNHG6andSNORD87 335/336
(99 %)
3 diff
(99.2 %id)
BG187066   .d 624 to 1432 39 to 833   tiling clone,   795/901
(88 %)
40 diff
(95.6 %id)
BG198927   .d 626 to 1424 1 to 793   tiling clone,   793/804
(98 %)
16 diff
(98.1 %id)
BG205659   .d 626 to 935 1 to 310       310/310
(100 %)
0 diff
(100 %id)
AW368488 head_neck .d 683 to 940 1 to 259       259/259
(100 %)
18 diff
(93.1 %id)
BF088237 head_neck .d 684 to 977 295 to 1       295/295
(100 %)
1 diff
(99.7 %id)
AW362019 colon .d 702 to 956 1 to 255       255/255
(100 %)
2 diff
(99.3 %id)
BF929993 nervous_tumor .d 829 to 1067 13 to 250       238/252
(94 %)
9 diff
(96.5 %id)
AK314145   .e 1 to 1005 9 to 1013 exact tiling clone,   1005/1005
(100 %)
2 diff
(99.9 %id)
DA610474   .e 1 to 559 9 to 567   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA568152 whole embryo, mainly head .e 70 to 894 2 to 835   tiling clone, capped   834/835
(99 %)
13 diff
(98.5 %id)
CN420953 embryonic stem cells, DMSO-treated H9 cellline .e 125 to 704 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DB354629 whole embryo, mainly head .e 1050 to 1536 485 to 1   tiling clone,   485/485
(100 %)
7 diff
(98.6 %id)
AL556503 placenta .f 1 to 474 1 to 480   tiling clone,   480/597
(80 %)
13 diff
(97.9 %id)
BM552474 leiomyosarcoma, uterus .f 123 to 495 1 to 373   tiling clone,   373/1350
(27 %)
7 diff
(99.5 %id)
CN369619 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 127 to 321 1 to 196       196/196
(100 %)
4 diff
(98.0 %id)
DB462423 testis .f 174 to 558 1 to 390       390/391
(99 %)
5 diff
(98.8 %id)
CN369618 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 197 to 448 1 to 252       252/252
(100 %)
2 diff
(99.3 %id)
DB468318 hippocampus .f 204 to 518 1 to 314       314/314
(100 %)
8 diff
(97.5 %id)
BG716352 brain, hypothalamus .f 215 to 484 1 to 270       270/270
(100 %)
4 diff
(98.6 %id)
DB503571 hypothalamus .f 221 to 699 1 to 479       479/479
(100 %)
2 diff
(99.6 %id)
DA697505   .f 221 to 490 2 to 274   capped   273/273
(100 %)
1 diff
(99.7 %id)
DB458228 testis .f 223 to 706 1 to 484       484/484
(100 %)
0 diff
(100 %id)
BQ719595 sympathetic trunk .f 223 to 745 1 to 527       527/1029
(51 %)
14 diff
(98.7 %id)
CR624412 fetal brain .f 224 to 1751 1 to 1528 exact     1528/1528
(100 %)
0 diff
(100 %id)
BM758392 stomach .f 225 to 489 1 to 265       265/265
(100 %)
0 diff
(100 %id)
BM759830 stomach .f 225 to 696 1 to 473       473/473
(100 %)
2 diff
(99.6 %id)
DA894736 skeletal muscle .f 226 to 490 2 to 266   capped   265/265
(100 %)
0 diff
(100 %id)
BM739266 Ascites, stomach .f 228 to 480 1 to 253       253/253
(100 %)
0 diff
(100 %id)
CR607535 Neuroblastoma Cot 50-normalized .f 229 to 1710 1 to 1482 exact     1482/1482
(100 %)
0 diff
(100 %id)
CR622410 placenta .f 231 to 1757 1 to 1527 exact     1527/1527
(100 %)
0 diff
(100 %id)
AL540980 placenta .f 231 to 892 1 to 660   fully sequenced,   660/660
(100 %)
7 diff
(99.0 %id)
CR621773 T cells (Jurkat cell line) Cot10-normalized .f 233 to 1777 1 to 1545 exact tiling clone,   1545/1545
(100 %)
0 diff
(100 %id)
BX386616   .f 233 to 1142 1 to 911       911/963
(94 %)
20 diff
(98.0 %id)
NM_006357.2   .f 233 to 1775 1 to 1543 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1543/1543
(100 %)
0 diff
(100 %id)
BM762761 lymph node, stomach .f 233 to 891 1 to 664       664/664
(100 %)
5 diff
(99.3 %id)
DB474885 hippocampus .f 236 to 734 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BI757282 brain .f 238 to 484 1 to 247       247/250
(98 %)
5 diff
(98.0 %id)
TI_57221589   .f 238 to 484 60 to 306       247/309
(79 %)
5 diff
(98.4 %id)
AL526312 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .f 244 to 942 1 to 697   fully sequenced,   595/595
(100 %)
30 diff
(95.0 %id)
CN369617 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 245 to 490 1 to 246       246/246
(100 %)
0 diff
(100 %id)
BM556650 amelanotic melanoma, cell line, skin .f 251 to 862 19 to 630       612/1101
(55 %)
8 diff
(99.3 %id)
CX167039 human embryonic stem cells differentiated toan early endodermal cell type .f 253 to 489 1 to 237       237/237
(100 %)
0 diff
(100 %id)
BP272325   .f 255 to 850 1 to 597       597/597
(100 %)
11 diff
(98.2 %id)
BC092407 Peripheral Nervous System, dorsal rootganglion .f 259 to 1775 1 to 1517 exact AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1517/1517
(100 %)
2 diff
(99.9 %id)
BM553120 amelanotic melanoma, cell line, skin .f 259 to 809 1 to 557       557/1268
(43 %)
15 diff
(98.9 %id)
BM424136 amelanotic melanoma, cell line, skin .f 259 to 995 1 to 743       743/1125
(66 %)
33 diff
(97.1 %id)
CX760078 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 259 to 496 1 to 238     Submitted on the opposite strand 238/238
(100 %)
1 diff
(99.6 %id)
DB499718 hypothalamus .f 260 to 750 1 to 492       492/492
(100 %)
2 diff
(99.6 %id)
CN369620 embryonic stem cells, cell lines H1, H7, andH9 .f 261 to 433 8 to 180       173/180
(96 %)
6 diff
(96.7 %id)
BU168371 adenocarcinoma, Pancreas .f 261 to 490 1 to 233       233/1119
(20 %)
2 diff
(99.9 %id)
BU151011 dorsal root ganglia .f 261 to 863 1 to 613       613/1058
(57 %)
18 diff
(98.3 %id)
CD674246 eye, lens .f 263 to 662 1 to 401       401/401
(100 %)
15 diff
(96.3 %id)
BM730004 insulinoma, Pancreas .f 265 to 769 7 to 511       505/511
(98 %)
9 diff
(98.3 %id)
CN369621 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 270 to 487 1 to 218       218/218
(100 %)
0 diff
(100 %id)
H84421 eye, retina .f 276 to 480 1 to 203       203/203
(100 %)
9 diff
(95.6 %id)
AA018518 eye, retina .f 277 to 467 1 to 188       188/188
(100 %)
9 diff
(95.3 %id)
AA059305 eye, retina .f 277 to 469 1 to 189       189/189
(100 %)
6 diff
(96.9 %id)
DA569701 whole embryo, mainly head .f 282 to 496 2 to 216   capped   215/233
(92 %)
5 diff
(97.9 %id)
DT218248 brain .f 283 to 521 1 to 240       240/249
(96 %)
8 diff
(96.8 %id)
CR616134 Neuroblastoma Cot 25-normalized .f 297 to 1751 1 to 1455 exact     1455/1455
(100 %)
0 diff
(100 %id)
BG326084 Kidney, renal cell adenocarcinoma .f 298 to 483 1 to 185       185/269
(68 %)
2 diff
(99.3 %id)
DR421637 eye, Pterygium .f 308 to 963 1 to 656       656/656
(100 %)
0 diff
(100 %id)
CN293471 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 328 to 489 9 to 170       162/170
(95 %)
6 diff
(96.5 %id)
BQ923830 epidermoid carcinoma, cell line, lung .f 331 to 1140 1 to 817       817/855
(95 %)
10 diff
(98.9 %id)
BE504278 carcinoid, lung .f 374 to 934 1 to 561     Submitted on the opposite strand 561/561
(100 %)
0 diff
(100 %id)
BP307674 brain .f 411 to 1008 1 to 598       598/598
(100 %)
2 diff
(99.7 %id)
DA604960   .f 412 to 553 2 to 143   capped   142/142
(100 %)
1 diff
(99.3 %id)
TI_1540413234   .f 413 to 1103 697 to 7       691/710
(97 %)
9 diff
(98.8 %id)
TI_1540413328   .f 413 to 1108 696 to 2       695/744
(93 %)
6 diff
(99.2 %id)
CR603132 Neuroblastoma Cot 25-normalized .f 430 to 1769 1 to 1340 exact     1340/1340
(100 %)
0 diff
(100 %id)
BX374923 Neuroblastoma Cot 25-normalized .f 430 to 1272 1 to 842 exact fully sequenced,   842/842
(100 %)
4 diff
(99.6 %id)
BP339655 Spleen .f 440 to 952 1 to 514       514/582
(88 %)
2 diff
(99.7 %id)
DT219990 brain .f 455 to 787 1 to 334       334/334
(100 %)
12 diff
(96.5 %id)
CB149439 Liver .f 457 to 797 1 to 340       340/340
(100 %)
9 diff
(97.4 %id)
Z45130 brain, total brain .f 463 to 742 1 to 280       280/280
(100 %)
5 diff
(98.3 %id)
AI057617 parathyroid gland, parathyroid tumor .f 474 to 1168 1 to 695     Submitted on the opposite strand 695/695
(100 %)
10 diff
(98.6 %id)
TI_1540413140   .f 483 to 1102 624 to 6       619/871
(71 %)
12 diff
(98.7 %id)
AA084553 pineal gland .f 484 to 861 1 to 379       379/441
(85 %)
10 diff
(97.8 %id)
CN420948 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 485 to 1041 7 to 563       557/568
(98 %)
7 diff
(98.8 %id)
CX786152 human embryonic stem cells .f 489 to 1359 4 to 875 exact     872/875
(99 %)
5 diff
(99.5 %id)
BX473264   .f 494 to 946 8 to 460       453/460
(98 %)
6 diff
(98.7 %id)
AU310088 neuroblastoma .f 494 to 1086 8 to 600       593/600
(98 %)
5 diff
(99.2 %id)
BP378772 uterus .f 494 to 1066 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
CD050868 embryonic trophoblasts, made from WA01 stemcells .f 495 to 1373 25 to 907 R65S S82C T202D K203Q     883/907
(97 %)
18 diff
(98.1 %id)
AF085362   .f 497 to 1775 1 to 1278 exact AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1278/1278
(100 %)
1 diff
(100.0 %id)
BQ441123 melanotic melanoma, skin .f 505 to 1204 1 to 705       705/929
(75 %)
6 diff
(99.4 %id)
BQ070497 brain, neuroblastoma, cell line .f 506 to 1408 1 to 917 A176G D177G P178S L179S V180G ...     917/1010
(90 %)
22 diff
(97.9 %id)
BG338047 leiomyosarcoma cell line, uterus .f 507 to 1362 1 to 858 N174X L188V H194P D195R R196Q ...     858/1109
(77 %)
31 diff
(97.3 %id)
CV812852 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 507 to 1283 1 to 778 T189N     778/778
(100 %)
7 diff
(99.2 %id)
BF684491 leiomyosarcoma cell line, uterus .f 508 to 1104 1 to 610       610/663
(92 %)
26 diff
(96.1 %id)
BU839598 hepatocellular carcinoma, cell line, Liver .f 511 to 1142 1 to 634       634/974
(65 %)
12 diff
(98.8 %id)
CN420952 embryonic stem cells, cell lines H1, H7, andH9 .f 513 to 941 1 to 432       432/432
(100 %)
3 diff
(99.4 %id)
CX754646 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 515 to 1248 1 to 727 N190T R191E A192Q E193T H194R ...   Submitted on the opposite strand 727/842
(86 %)
8 diff
(99.1 %id)
BC003554 Lung, small cell carcinoma .f 516 to 1771 1 to 1256 exact available from MGC, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1256/1256
(100 %)
0 diff
(100 %id)
CX752299 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 518 to 1330 1 to 807 K203X A206X   Submitted on the opposite strand 807/810
(99 %)
12 diff
(98.6 %id)
BM847774 myeloma .f 520 to 1082 1 to 563       563/563
(100 %)
0 diff
(100 %id)
BE261321 brain, neuroblastoma .f 522 to 923 1 to 400       400/401
(99 %)
12 diff
(97.1 %id)
AA384632 thyroid gland .f 526 to 861 1 to 339       339/343
(98 %)
8 diff
(97.7 %id)
AU102616   .f 529 to 578 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BU727759 eye, eye anterior segment .f 529 to 754 12 to 237     Submitted on the opposite strand 226/237
(95 %)
4 diff
(98.4 %id)
AW958929   .f 532 to 1140 9 to 617       609/630
(96 %)
2 diff
(99.7 %id)
CX759885 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 532 to 1303 1 to 772 exact   Submitted on the opposite strand 772/775
(99 %)
1 diff
(99.9 %id)
AA974936 carcinoid, lung .f 533 to 992 1 to 462     Submitted on the opposite strand 462/467
(98 %)
4 diff
(99.2 %id)
BM795320 stomach .f 533 to 1229 1 to 696       696/696
(100 %)
1 diff
(99.9 %id)
DT215723 brain .f 535 to 881 11 to 357       347/347
(100 %)
0 diff
(100 %id)
BE265673 lung, small cell carcinoma .f 535 to 973 1 to 439       439/442
(99 %)
4 diff
(99.1 %id)
AU098426   .f 536 to 828 8 to 300       293/293
(100 %)
0 diff
(100 %id)
BP204970 coronary artery .f 536 to 1109 8 to 582       575/575
(100 %)
2 diff
(99.7 %id)
AA806385 germinal center B cell .f 536 to 1014 8 to 485     Submitted on the opposite strand 478/479
(99 %)
3 diff
(99.4 %id)
W46670 senescent fibroblast .f 539 to 941 1 to 404       403/405
(99 %)
9 diff
(97.8 %id)
BE562759 endometrium, adenocarcinoma cell line, uterus .f 539 to 1396 1 to 862 K203Q R204E Y205I A206R T207N     862/987
(87 %)
25 diff
(97.5 %id)
BE562767 endometrium, adenocarcinoma cell line, uterus .f 539 to 1327 1 to 791 L163C L164C S165L I166F C167V ...     791/998
(79 %)
21 diff
(97.9 %id)
BE515156 endometrium, adenocarcinoma cell line, uterus .f 540 to 1253 1 to 729 F110L F111Y L112S D113G I114Y ...     729/1152
(63 %)
25 diff
(97.9 %id)
AA878448 carcinoid, lung .f 541 to 1123 1 to 583     Submitted on the opposite strand 583/583
(100 %)
6 diff
(99.0 %id)
BE222487 carcinoid, lung .f 541 to 1142 1 to 602     Submitted on the opposite strand 602/610
(98 %)
0 diff
(100 %id)
AL524371.
matches multiple genes
brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .f 547 to 1115 250 to 818     also hits gene UBE2E4P 753/818
(92 %)
14 diff
(98.3 %id)
DR159510 human embryonic stem cells differentiated toan early endodermal cell type .f 548 to 1348 1 to 801 exact     801/801
(100 %)
1 diff
(99.9 %id)
DN989955 brain, whole brain .f 549 to 1262 1 to 714 exact     714/714
(100 %)
4 diff
(99.5 %id)
CB136926 Liver .f 551 to 967 1 to 416       416/416
(100 %)
2 diff
(99.6 %id)
F08633 brain, total brain .f 680 to 927 1 to 249       249/249
(100 %)
2 diff
(99.2 %id)
AL529830.
matches multiple genes
brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .f 804 to 1710 905 to 1     also hits gene UBE2E4P 905/1069
(84 %)
9 diff
(99.2 %id)
BX386615   .f 804 to 1715 913 to 1       913/981
(93 %)
9 diff
(99.1 %id)
BU942426 mixed (pool of 40 RNAs) .f 810 to 1513 1 to 708       708/749
(94 %)
14 diff
(98.2 %id)
BG191264   .f 811 to 1536 1 to 714       714/738
(96 %)
24 diff
(96.8 %id)
BG211403   .f 811 to 1638 1 to 826       826/827
(99 %)
21 diff
(97.5 %id)
BM790782 stomach .f 816 to 1502 1 to 686       686/686
(100 %)
1 diff
(99.9 %id)
BI770642 pooled lung and spleen .f 821 to 1626 1 to 804       804/804
(100 %)
8 diff
(99.1 %id)
AL568675 placenta .f 831 to 1757 926 to 1   fully sequenced,   926/926
(100 %)
12 diff
(98.8 %id)
BG165233 hypernephroma, cell line, Kidney .f 831 to 1718 1 to 877       877/880
(99 %)
34 diff
(96.2 %id)
BP264935 muscle .f 832 to 1639 1 to 821       821/879
(93 %)
14 diff
(98.5 %id)
BM709745 eye, Retina Foveal and Macular .f 839 to 1157 1 to 319   fully sequenced, Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 319/319
(100 %)
0 diff
(100 %id)
BG219830   .f 857 to 1537 1 to 687       687/825
(83 %)
68 diff
(91.8 %id)
BG197885   .f 858 to 1675 1 to 823       823/823
(100 %)
37 diff
(95.6 %id)
BG208700   .f 860 to 1491 269 to 908       640/910
(70 %)
50 diff
(94.6 %id)
BG215715   .f 860 to 1467 70 to 672       603/856
(70 %)
37 diff
(95.7 %id)
TI_57183551   .f 860 to 1626 69 to 834       766/834
(91 %)
13 diff
(98.5 %id)
BX441656 brain, fetal brain .f 861 to 1735 867 to 1       867/867
(100 %)
46 diff
(94.7 %id)
BX352327   .f 864 to 1777 915 to 1       915/915
(100 %)
22 diff
(97.6 %id)
AL556502 placenta .f 865 to 1720 877 to 20       858/881
(97 %)
13 diff
(98.6 %id)
BU190309 epithelioid carcinoma, Pancreas .f 873 to 1694 1 to 822       822/848
(96 %)
9 diff
(99.0 %id)
BG252265 adenocarcinoma, cell line, Liver .f 875 to 1565 1 to 693       693/697
(99 %)
4 diff
(99.5 %id)
BE018406 cervix .f 882 to 1331 1 to 450   fully sequenced,   450/450
(100 %)
0 diff
(100 %id)
AA025668 heart .f 883 to 1324 1 to 454   fully sequenced,   454/454
(100 %)
12 diff
(97.4 %id)
CN420950 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 884 to 1563 49 to 729       681/729
(93 %)
7 diff
(99.1 %id)
AA280089 germinal center B cell .f 896 to 1464 1 to 569   fully sequenced,   569/569
(100 %)
0 diff
(100 %id)
W68762 heart .f 897 to 1350 1 to 457   fully sequenced,   457/457
(100 %)
6 diff
(98.7 %id)
BP383572   .f 907 to 1405 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
AL526279 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .f 912 to 1738 830 to 6   fully sequenced,   825/830
(99 %)
2 diff
(99.8 %id)
BG292360 bladder, transitional cell papilloma, cell line .f 915 to 1507 14 to 605       592/606
(97 %)
21 diff
(96.6 %id)
BU178864 eye, retinoblastoma .f 917 to 1773 1 to 859       859/895
(95 %)
9 diff
(99.0 %id)
TI_57168569   .f 940 to 1779 34 to 875       842/884
(95 %)
15 diff
(98.4 %id)
TI_57168709   .f 940 to 1680 35 to 777       743/777
(95 %)
12 diff
(98.5 %id)
TI_154111360   .f 940 to 1771 914 to 87   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 830/961
(86 %)
8 diff
(99.2 %id)
TI_154116869   .f 940 to 1774 924 to 97   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 828/976
(84 %)
13 diff
(98.7 %id)
BI833155 pooled pancreas and spleen .f 941 to 1779 1 to 841       841/850
(98 %)
7 diff
(99.2 %id)
BI833006 pooled pancreas and spleen .f 941 to 1680 1 to 742       742/742
(100 %)
6 diff
(99.2 %id)
BY796654 eye .f 943 to 1548 1 to 606       606/606
(100 %)
2 diff
(99.7 %id)
BG193358   .f 962 to 1760 812 to 18     Submitted on the opposite strand 795/814
(97 %)
18 diff
(97.8 %id)
BG215153   .f 965 to 1763 808 to 12     Submitted on the opposite strand 799/808
(98 %)
9 diff
(98.9 %id)
BM006938 ductal carcinoma, cell line, Pancreas .f 992 to 1694 718 to 1       716/981
(72 %)
23 diff
(97.7 %id)
TI_59395828   .f 992 to 1694 718 to 1       716/981
(72 %)
23 diff
(97.7 %id)
BG195836   .f 993 to 1761 788 to 14     Submitted on the opposite strand 773/884
(87 %)
20 diff
(97.8 %id)
BG198930   .f 993 to 1763 782 to 13     Submitted on the opposite strand 770/815
(94 %)
18 diff
(97.8 %id)
BG210387   .f 993 to 1761 790 to 20     Submitted on the opposite strand 771/983
(78 %)
21 diff
(97.9 %id)
BG194975   .f 994 to 1765 778 to 11     Submitted on the opposite strand 768/842
(91 %)
13 diff
(98.5 %id)
BG197374   .f 994 to 1762 782 to 13     Submitted on the opposite strand 770/845
(91 %)
15 diff
(98.3 %id)
W35340 heart .f 994 to 1414 1 to 425       425/425
(100 %)
7 diff
(98.4 %id)
BG202017   .f 995 to 1763 773 to 14     Submitted on the opposite strand 760/834
(91 %)
13 diff
(98.5 %id)
AA873629 Kidney .f 996 to 1774 776 to 1       776/826
(93 %)
54 diff
(93.5 %id)
TI_149306937   .f 997 to 1776 858 to 84   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 775/924
(83 %)
11 diff
(98.9 %id)
TI_154060664   .f 998 to 1771 866 to 95   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 772/990
(77 %)
6 diff
(99.4 %id)
TI_149308777   .f 1001 to 1776 882 to 107   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 776/957
(81 %)
24 diff
(97.5 %id)
BP422855 small intestine .f 1003 to 1518 1 to 516     Submitted on the opposite strand 516/516
(100 %)
2 diff
(99.7 %id)
CB133819 Liver .f 1004 to 1587 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
CB158326 Liver .f 1004 to 1525 1 to 522       522/522
(100 %)
1 diff
(99.9 %id)
BE295640 muscle, rhabdomyosarcoma .f 1008 to 1523 1 to 516       516/517
(99 %)
1 diff
(99.9 %id)
BI084177.
matches multiple genes
epidermoid carcinoma, cell line, salivary gland .f 1008 to 1771 1 to 765   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base), also hits gene UBE2E4P 765/765
(100 %)
12 diff
(98.5 %id)
BQ671609 epidermoid carcinoma, cell line, salivary gland .f 1011 to 1685 1 to 676       676/933
(72 %)
13 diff
(98.7 %id)
CF995313 Pooled Chondrosarcoma Tumor cells .f 1011 to 1644 7 to 639       633/910
(69 %)
22 diff
(97.6 %id)
AI982853 adenocarcinoma, Pancreas .f 1012 to 1775 761 to 1       761/781
(97 %)
29 diff
(96.3 %id)
BG192819   .f 1018 to 1761 754 to 14     Submitted on the opposite strand 741/803
(92 %)
20 diff
(97.6 %id)
TI_149307873   .f 1032 to 1771 860 to 130   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 731/882
(82 %)
14 diff
(98.5 %id)
BG189751   .f 1033 to 1763 736 to 16     Submitted on the opposite strand 721/926
(77 %)
25 diff
(97.4 %id)
W72840 heart .f 1040 to 1390 1 to 352   fully sequenced,   352/352
(100 %)
1 diff
(99.8 %id)
BF839452 head_neck .f 1041 to 1586 7 to 552       546/552
(98 %)
7 diff
(98.8 %id)
W69530 heart .f 1042 to 1361 1 to 323   fully sequenced,   323/323
(100 %)
2 diff
(99.4 %id)
BE304909 adenocarcinoma cell line, colon .f 1044 to 1453 422 to 12       411/422
(97 %)
1 diff
(99.8 %id)
W92405 heart .f 1045 to 1434 1 to 391   fully sequenced,   391/391
(100 %)
1 diff
(99.8 %id)
W86132 liver and spleen .f 1045 to 1356 9 to 328   fully sequenced,   320/328
(97 %)
8 diff
(97.6 %id)
W69899 heart .f 1050 to 1396 1 to 351   fully sequenced,   351/351
(100 %)
6 diff
(98.3 %id)
BG202016   .f 1053 to 1763 719 to 17     Submitted on the opposite strand 703/940
(74 %)
21 diff
(97.8 %id)
BG217809   .f 1053 to 1762 718 to 13     Submitted on the opposite strand 706/890
(79 %)
15 diff
(98.4 %id)
CB243546 Human Lung Epithelial cells, lung .f 1063 to 1771 727 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 709/709
(100 %)
0 diff
(100 %id)
BE252066 eye, retinoblastoma .f 1064 to 1598 1 to 534       534/534
(100 %)
1 diff
(99.9 %id)
BM694999 eye, human retina .f 1074 to 1320 1 to 247   fully sequenced, Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 247/247
(100 %)
0 diff
(100 %id)
TI_149288710   .f 1078 to 1776 777 to 79   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 699/699
(100 %)
0 diff
(100 %id)
DA381236 thalamus .f 1091 to 1617 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
W00672 lung .f 1112 to 1557 1 to 427   fully sequenced,   427/427
(100 %)
9 diff
(97.9 %id)
AA022773 heart .f 1112 to 1290 1 to 179       179/180
(99 %)
1 diff
(99.5 %id)
CA420165 Bone, Human Chondrosarcoma Cell Line .f 1117 to 1771 672 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 654/654
(100 %)
1 diff
(99.9 %id)
BU608985 Human Lung Epithelial cells, lung .f 1118 to 1778 677 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 661/661
(100 %)
0 diff
(100 %id)
CA448392 Chondrosarcoma, Left Pubic Bone .f 1118 to 1771 672 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 654/654
(100 %)
0 diff
(100 %id)
CA449623 Chondrosarcoma, Left Pelvis .f 1118 to 1774 671 to 16   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 656/656
(100 %)
1 diff
(99.9 %id)
CA308051 Alveolar Macrophage, lung .f 1118 to 1776 675 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 657/657
(100 %)
1 diff
(99.9 %id)
AA648914 germinal center B cell .f 1119 to 1776 675 to 18   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 658/659
(99 %)
15 diff
(97.8 %id)
AI133513 Liver .f 1126 to 1771 672 to 27   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 646/646
(100 %)
0 diff
(100 %id)
BU630586 cell lines, Chondrosarcoma .f 1127 to 1771 663 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 645/645
(100 %)
0 diff
(100 %id)
BQ005787 Chondrosarcoma, Left Pubic Bone .f 1133 to 1778 662 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 646/646
(100 %)
0 diff
(100 %id)
BM978888 lung, Primary Lung Epithelial Cells .f 1133 to 1776 662 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 644/644
(100 %)
2 diff
(99.7 %id)
BU733700 eye, Retina Foveal and Macular .f 1154 to 1776 640 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 622/622
(100 %)
1 diff
(99.9 %id)
DB356391 whole embryo, mainly head .f 1214 to 1776 564 to 1       564/566
(99 %)
12 diff
(97.9 %id)
BX392119 Neuroblastoma Cot 25-normalized .f 1242 to 1768 527 to 1   fully sequenced,   527/527
(100 %)
6 diff
(98.9 %id)
BM666789 eye, human retina .f 1290 to 1778 505 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 489/489
(100 %)
0 diff
(100 %id)
BE302017 cervix .f 1301 to 1780 480 to 1   fully sequenced,   480/480
(100 %)
3 diff
(99.4 %id)
W68616 heart .f 1320 to 1772 453 to 1   fully sequenced,   453/453
(100 %)
0 diff
(100 %id)
AA025669 heart .f 1321 to 1775 462 to 9   fully sequenced,   454/462
(98 %)
0 diff
(100 %id)
W86098 liver and spleen .f 1326 to 1778 451 to 1   fully sequenced,   451/451
(100 %)
2 diff
(99.6 %id)
W69447 heart .f 1331 to 1772 444 to 1   fully sequenced,   444/444
(100 %)
6 diff
(98.7 %id)
W72841 heart .f 1360 to 1775 425 to 1   fully sequenced,   425/425
(100 %)
11 diff
(97.5 %id)
W69900 heart .f 1369 to 1778 418 to 1   fully sequenced,   418/418
(100 %)
12 diff
(97.2 %id)
W92406 heart .f 1404 to 1751 349 to 1   fully sequenced,   349/349
(100 %)
3 diff
(99.2 %id)
W46477 senescent fibroblast .f 1414 to 1771 357 to 1       357/357
(100 %)
1 diff
(99.8 %id)
AA059201 eye, retina .f 1430 to 1776 353 to 1       353/405
(87 %)
11 diff
(97.3 %id)
AA280018 germinal center B cell .f 1446 to 1778 333 to 1   fully sequenced,   333/333
(100 %)
0 diff
(100 %id)
AA018468 eye, retina .f 1458 to 1776 323 to 1       323/376
(85 %)
4 diff
(99.0 %id)
Z40864 brain, total brain .f 1490 to 1771 282 to 1       282/282
(100 %)
0 diff
(100 %id)
AA022626 heart .f 1505 to 1777 277 to 4       274/277
(98 %)
0 diff
(100 %id)
H84422 eye, retina .f 1508 to 1754 249 to 1       249/249
(100 %)
2 diff
(99.2 %id)
W23741 heart .f 1508 to 1770 263 to 1       263/265
(99 %)
2 diff
(99.3 %id)
N69042 lung .f 1527 to 1782 261 to 2   fully sequenced,   260/261
(99 %)
5 diff
(98.1 %id)
F01896 brain, total brain .f 1580 to 1776 196 to 1       196/196
(100 %)
5 diff
(97.5 %id)
BI711600 insulinoma, Pancreas .g 255 to 460 306 to 511       505/511
(98 %)
43 diff
(91.6 %id)
BG216085   .g 283 to 622 1 to 340   tiling clone,   340/340
(100 %)
2 diff
(99.5 %id)
AA912856.
matches multiple genes
pooled .g 323 to 545 223 to 1   tiling clone, also hits gene UBE2E4P 223/223
(100 %)
7 diff
(96.9 %id)
BG189159   .h 1 to 659 1 to 663 S118F D119R Y120L P121S F122I ... tiling clone,   663/807
(82 %)
26 diff
(96.8 %id)
BG181271   .h 102 to 655 1 to 550 S140R Q141S V143K I144Y C145L ...     550/765
(71 %)
17 diff
(97.8 %id)
BG198384   .h 102 to 625 269 to 790       522/790
(66 %)
20 diff
(97.5 %id)
CD688292 normal nasopharynx .h 102 to 611 40 to 549       510/549
(92 %)
6 diff
(99.0 %id)
ES311250 frontal balding hair, skin .h 102 to 244 20 to 157       138/157
(87 %)
4 diff
(97.5 %id)
BG182365   .h 104 to 438 1 to 335       335/337
(99 %)
6 diff
(98.3 %id)
BG186578   .h 104 to 461 1 to 358       358/358
(100 %)
1 diff
(99.8 %id)
BG203567   .h 104 to 655 1 to 557 F110V F116L F122L R130A T131H ...     557/805
(69 %)
24 diff
(97.1 %id)
N32767 placenta .h 108 to 607 1 to 501     Submitted on the opposite strand 501/512
(97 %)
5 diff
(99.1 %id)
AA255941 germinal center B cell .h 108 to 475 1 to 368     Submitted on the opposite strand 368/369
(99 %)
1 diff
(99.8 %id)
BM987442 mixed .h 120 to 513 451 to 58       394/451
(87 %)
1 diff
(99.8 %id)
CN420947 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 128 to 586 1 to 459       459/459
(100 %)
0 diff
(100 %id)
CV025917 mixed .h 129 to 639 1 to 511       511/511
(100 %)
0 diff
(100 %id)
TI_1948090351   .h 129 to 641 135 to 647       513/542
(94 %)
6 diff
(98.9 %id)
BI480874 Native Retinal Pigment Epithelium sheets, retina .h 156 to 459 11 to 314       304/321
(94 %)
7 diff
(97.9 %id)
CB119379 Liver .h 158 to 647 1 to 490       490/490
(100 %)
2 diff
(99.6 %id)
CB135485 Liver .h 197 to 651 1 to 455   tiling clone,   455/455
(100 %)
0 diff
(100 %id)
W37082 lung .h 285 to 641 13 to 373       361/496
(72 %)
10 diff
(98.0 %id)
BE782364 eye, retinoblastoma .h 322 to 618 1 to 299       299/545
(54 %)
6 diff
(98.9 %id)
BM849628 stomach .h 329 to 622 1 to 294       294/294
(100 %)
0 diff
(100 %id)
BG216775   .h 372 to 641 71 to 340       270/340
(79 %)
10 diff
(97.1 %id)
BG196396   .h 374 to 560 1 to 188       188/188
(100 %)
1 diff
(99.5 %id)
BG203090   .h 374 to 625 13 to 266       254/266
(95 %)
8 diff
(97.0 %id)
AW629168 pooled .i 1 to 446 448 to 3 S20L A29V P32L S41F tiling clone,   446/448
(99 %)
6 diff
(98.7 %id)
AA629248   .i 21 to 446 430 to 5 C86S tiling clone,   426/430
(99 %)
2 diff
(99.6 %id)
BU963783 mixed (pool of 40 RNAs) .j 1 to 569 1 to 571 S19G P30A L51R Q67P L75P ... tiling clone,   571/786
(72 %)
31 diff
(96.1 %id)
CD385351 embryonic trophoblasts, made from WA01 stemcells .k 1 to 369 18 to 386 exact tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 369/386
(95 %)
6 diff
(98.5 %id)
DA376169 thalamus .l 1 to 552 2 to 554   tiling clone, capped   553/553
(100 %)
2 diff
(99.7 %id)
BX486982   .l 27 to 507 1 to 485   tiling clone,   485/485
(100 %)
5 diff
(99.0 %id)
BI032695 nervous_normal .l 303 to 712 426 to 19       408/426
(95 %)
0 diff
(100 %id)
DA136247 alzheimer cortex .l 518 to 1155 2 to 639   tiling clone, capped   638/638
(100 %)
2 diff
(99.7 %id)
EL950561 eyeball .l 865 to 995 30 to 160       131/160
(81 %)
6 diff
(96.3 %id)
CB143937 Liver .l 899 to 1307 1 to 409   tiling clone,   409/409
(100 %)
0 diff
(100 %id)
DB311170 thalamus .l 1624 to 2139 516 to 1   tiling clone,   516/516
(100 %)
2 diff
(99.7 %id)
DB308844 hippocampus .m-u 1 to 568 568 to 1   tiling clone,   568/568
(100 %)
0 diff
(100 %id)
BG186232   .m-u 288 to 632 1 to 342 I4S P5H A6T L7V W8E ... tiling clone,   342/342
(100 %)
11 diff
(96.8 %id)
DA512072 brain .n 1 to 498 2 to 499 exact tiling clone, capped   498/498
(100 %)
0 diff
(100 %id)
BF725899 eye, Iris .n 30 to 600 9 to 579 exact tiling clone,   571/579
(98 %)
6 diff
(99.0 %id)
BG196397   .n 34 to 368 36 to 369 R36W L38X S39P A40H P41Q ...     599/792
(75 %)
28 diff
(96.5 %id)
BG187676   .n 37 to 435 1 to 399 exact     399/399
(100 %)
0 diff
(100 %id)
AW007409 adenocarcinoma, Pancreas .o-u 1 to 476 471 to 1 F27S Q28E K29E R30V C31W ... tiling clone,   471/471
(100 %)
9 diff
(98.1 %id)
AA911659 pooled .p-u 1 to 379 379 to 1 exact tiling clone,   379/379
(100 %)
0 diff
(100 %id)
AA522460 metastatic prostate bone lesion .p-u 230 to 385 1 to 156   tiling clone,   156/159
(98 %)
3 diff
(98.2 %id)
T89010 liver and spleen .q 1 to 350 1 to 358 T57D S58I T61D T62N G63W ... tiling clone,   358/485
(73 %)
10 diff
(98.0 %id)
CX754558 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .r-u 1 to 235 1 to 235 exact tiling clone, AAA Submitted on the opposite strand 235/235
(100 %)
0 diff
(100 %id)
CB136572 Liver .r-u 22 to 211 1 to 190       190/190
(100 %)
4 diff
(97.9 %id)
CN420955 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .r-u 34 to 219 1 to 186       186/186
(100 %)
0 diff
(100 %id)
BM707875.
matches multiple genes
eye, RPE and Choroid Gene UBE2E4P, variant not shown         Suspected internal deletion, suspected internal deletion, suspected internal deletion, this clone was ignored, also hits gene UBE2E4P    
BM707875.
matches multiple genes
eye, RPE and Choroid Gene UBE2E3, variant not shown         Suspected internal deletion, suspected internal deletion, suspected internal deletion, this clone was ignored, also hits gene UBE2E4P    
BU732962.
matches multiple genes
eye, RPE and Choroid Gene UBE2E4P, variant not shown       AAA Suspected internal deletion, suspected internal deletion, suspected internal deletion, this clone was ignored, also hits gene UBE2E4P    
BU732962.
matches multiple genes
eye, RPE and Choroid Gene UBE2E3, variant not shown       AAA Suspected internal deletion, suspected internal deletion, suspected internal deletion, this clone was ignored, also hits gene UBE2E4P    
AV744297 cord Blood Gene UBE2E3, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n, .o-u, .p-u, .q, .r-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI